Riskpilot← Back to searchSign inGet full accessMEDIBOVA AB
ABActiveOrg 5566439344Bergsbovägen 17 F Lgh 1003Business and other management consultancy activities · NACE 7020Est. 20031 employees
Revenue 2025
SEK 0
EBITDA margin
—
+27% vs 2024
Equity ratio
99.2%
Financial strength
Net profit 2025
SEK -108K
+33% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -149K | +27% |
| Net profit | SEK -108K | +33% |
| Total assets | SEK 2,8M | -5% |
| Equity | SEK 2,7M | -4% |
| Employees | 1 | — |
Legal name
MEDIBOVA AB
Org number
5566439344
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
29 april 2003
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten Firman tecknas ensam av Sjöberg, Bo Göran
Company purpose
Bolaget ska bedriva konsulttjänst inom sjukvård, utbildning, förvaltning av värdepapper samt därmed förenlig verksamhet.
Address
Bergsbovägen 17 F Lgh 1003
Email
bo.sjoberg@pajala.nu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | −0 | 0 | 0 |
| Staff expenses | — | −73 | −60 | −70 | −75 |
| EBITDA | −269 | −280 | −158 | −202 | −149 |
| Depreciation & amort. | −40 | −41 | −41 | −30 | — |
| EBIT | −309 | −321 | −198 | −233 | −149 |
| Net financials | 61 | 17 | 23 | 71 | 41 |
| Profit before tax | −126 | 316 | −56 | −162 | −108 |
| Tax | −3 | −75 | — | — | — |
| Net profit | −129 | 242 | −56 | −162 | −108 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 607 | 3 244 | 3 061 | 2 899 | 2 755 |
| Equity | 2 817 | 3 058 | 3 002 | 2 840 | 2 732 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 52 | 66 | 59 | 59 | 23 |
| Total debt | 52 | 66 | 59 | 59 | 23 |
EBITDA margin
-14852100.0%
This company
15.8%
Market median
-94000733% vs market
20212025
Equity ratio
99.2%
This company
38.2%
Market median
+160% vs market
20212025
Return on equity
-4.0%
This company
18.4%
Market median
-122% vs market
20212025
Net profit margin
-10799700.0%
This company
8.1%
Market median
-133329730% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BG External Signatory | External Signatory | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDIBOVA AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bo Göran Sjöberg | External Signatory | 0 companies |
| Eva Katarina Ylipää Sjöberg | Board of Directors | 0 companies |
| Per Seleborg | Deputy Board Member | 0 companies |